$CTIX Recent Headlines

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$CTIX Recent Headlines







Update: Cellceutix Calls Out To President Obama About Brilacidin

3:38 p.m. Sept. 21, 2014
- Seeking Alpha




10-K: CELLCEUTIX CORP
1:53 p.m. Sept. 15, 2014
- Edgar Online - (EDG = 10Q, 10K)





Update: Cellceutix's Antibiotic Brilacidin Should Move Share Price Before Kevetrin Or Prurisol

3:06 a.m. Sept. 14, 2014
- Seeking Alpha





The Antibiotic Resistance Triple Threat

2:05 p.m. Sept. 4, 2014
- Seeking Alpha





Cellceutix completes enrollment in Brilacidin trial

9:45 a.m. Aug. 19, 2014
- Seeking Alpha





Did The Medicines Company Trump Cellceutix And Others In A $1B-Plus Skin Infection Market?

11:38 a.m. Aug. 14, 2014
- Seeking Alpha




10-Q: CELLCEUTIX CORP
10:15 a.m. May 12, 2014
- Edgar Online - (EDG = 10Q, 10K)





Huge Opportunities Are Now Possible Due To Market Inefficiencies In Valuing Antibiotic Companies Such As Cubist, Durata, And Cellceutix

10:34 a.m. April 25, 2014
- Seeking Alpha




10-Q: CELLCEUTIX CORP
5:09 p.m. Feb. 10, 2014
- Edgar Online - (EDG = 10Q, 10K)





Cellceutix Is Significantly Undervalued Considering The Value Of Brilacidin

10:31 a.m. Jan. 28, 2014
- Seeking Alpha





Cellceutix Corp.: A Biotech With High Risk But High Reward

4:17 p.m. Jan. 2, 2014
- Wall St. Cheat Sheet





Cellceutix: An Undiscovered Company Set To Rise In 2014

10:06 a.m. Dec. 16, 2013
- Seeking Alpha





3 Innovative Biotech Companies Poised To Shine At TAP Partnership Conference

6:38 a.m. Nov. 19, 2013
- Seeking Alpha




10-Q: CELLCEUTIX CORP
6:06 p.m. Nov. 8, 2013
- Edgar Online - (EDG = 10Q, 10K)




10-K: CELLCEUTIX CORP
4:01 p.m. Sept. 30, 2013
- Edgar Online - (EDG = 10Q, 10K)




10-Q: CELLCEUTIX CORP
2:18 p.m. May 20, 2013
- Edgar Online - (EDG = 10Q, 10K)





Interview with CEO of Cellceutix Corporation: Leo Ehrlich

9:57 a.m. Nov. 15, 2011
- GuruFocus.com









Cellceutix to President Obama: We Have the Tools and Will Rise Up to
the Challenge to Prevent Antibiotic Resistant Bacteria Becoming a
Serious Threat to Public Health
7:15 a.m. Sept. 19, 2014
- Marketwire




Cellceutix Provides Initial Observations of Completed ABSSSI Phase 2b
Trial; Company Submits Investigational New Drug Application to FDA
for Phase 2 Trial of Brilacidin-OM for Oral Mucositis
3:01 p.m. Sept. 9, 2014
- Marketwire




Cellceutix to Present at Rodman & Renshaw's 16th Annual Global
Investment Conference
11:17 a.m. Sept. 5, 2014
- Marketwire




Cellceutix Appoints Dr. Barry Schechter to Board of Directors as
Company Focuses on Meeting Requirements for Stock Exchange Uplisting
7:01 a.m. Sept. 2, 2014
- Marketwire




Cellceutix Completes Enrollment in Phase 2b Clinical Trial of
Brilacidin for Acute Bacterial Skin and Skin Structure Infections
(ABSSSI)
8:31 a.m. Aug. 19, 2014
- Marketwire




Cellceutix Prepares for Phase 2 Clinical Trial of Brilacidin-OM for
Oral Mucositis
7:01 a.m. Aug. 11, 2014
- Marketwire




Cellceutix Anti-Psoriasis Drug Prurisol Meets Primary Endpoint of
Clinical Trial
6:04 a.m. Aug. 8, 2014
- Marketwire




Cellceutix Believes Brilacidin on Track to Help U.S. Avoid Falling
Into Post-Antibiotic Era; Completion of Enrollment in Phase 2b Trial
for Acute Bacterial Skin and Skin Structure Infections Expected This
Month
7:01 a.m. Aug. 4, 2014
- Marketwire




Cellceutix Announces Breakthrough in the Formulation of Its Novel
Antibiotic Brilacidin(TM), Plans Studies to Treat Diabetic Foot
Ulcers
7:01 a.m. July 14, 2014
- Marketwire




Cellceutix Brilacidin ABSSSI Trial Gets Positive Review by Data
Safety Monitoring Board; Best Possible Outcome, No Treatment-Related
Serious Adverse Events (SAEs)
7:00 a.m. July 7, 2014
- Marketwire




Cellceutix Anti-Fungal Compounds Awarded $1.5 Million SBIR Grant
7:01 a.m. June 23, 2014
- Marketwire




Cellceutix Clinical Trial of Anti-Cancer Drug Kevetrin Entering
Eighth Cohort
7:01 a.m. June 16, 2014
- Marketwire




Cellceutix Completes Patient Enrollment in Clinical Trial of Prurisol
7:02 a.m. June 2, 2014
- Marketwire




Cellceutix Signs Material Transfer Agreements for Defensin Mimetic
Compounds With Leading Universities
7:02 a.m. May 27, 2014
- Marketwire




Cellceutix Plans for Entry in Diabetic Foot Wound and Ulcer Market
7:01 a.m. May 19, 2014
- Marketwire




Cellceutix Confident in Its Formidable Antibiotic Arsenal
7:01 a.m. May 12, 2014
- Marketwire




Cohort Completed in Cellceutix Clinical Trial of Prurisol for
Psoriasis
5:56 a.m. May 7, 2014
- Marketwire




Top Five Daily Small Cap Trading List: InVivo Therapeutics Holding Corp, Vapor Group, Inc., Cellceutix Corp, Agenus, Magellan Petroleum Corp
10:02 a.m. April 29, 2014
- PR Newswire - PRF




Cellceutix Corp. Reports Favorable Results on Trial of New Antibiotic
9:08 a.m. April 28, 2014
- ACCESSWIRE




Study Shows Cellceutix Antibiotic Active Against Drug-Resistant
Superbug Klebsiella Pneumoniae
6:31 a.m. April 14, 2014
- Marketwire




Scroll down for more posts ▼

Top 10 Most Recent News Articles

West Texas Weather Shapes Home Design Decisions

Updated Category News Views 2

West Texas Weather: A Tough Customer for Home Builders You'd think building a house is a straightforward gig, but slap it down in West Texas, and we're talking a whole different ballgame. With its brutal heat, howling winds, and wild temperature swings, Odessa isn't just painting by numbers. It's where Mother Nature is your uninvited consultant on every single...

Continue Reading
Jollibee and DreamWorks Unite for Cultural Celebration

Updated Category News Views 2

Jollibee Partners with DreamWorks Animation Never thought I’d see the day: Jollibee, that familiar face of fast food, teaming up with the creative juggernaut DreamWorks Animation. They’re calling it a celebration of friendship and Filipino culture, wrapped up neatly in the context of a flick called Forgotten Island. Set to sizzle in theaters on September 25, 2026,...

Continue Reading
WaFd and EverBank $3.9B Deal Spurs Big Bank Shift

Updated Category News Views 4

Remember the good old days when banking was just about collecting interest? Now it's all about combining forces to bolster strength, and that's just what we're seeing with WaFd, Inc. (NASDAQ: WAFD) and EverBank Financial Corp flipping the script and shaking hands on a $3.9 billion reverse merger. Strategic Vision: A New Chapter They're calling it a 'strategic...

Continue Reading
Tiger Group to Auction Huge Window Manufacturing Plant

Updated Category News Views 1

Glass & Vinyl Ambitions: A New Chapter Who would have guessed? The seasoned window maker Showcase Window and Door Company is putting its prime manufacturing facility up for grabs. The online auction, orchestrated by Tiger Group, kicks off September 10, and it's sure to stir up some excitement in the industry. With picking up operations now within reach, it feels like...

Continue Reading
India's First Upright Proton Therapy System Unveiled

Updated Category News Views 3

A Leap Forward in Cancer Care: Proton Therapy Revolution Dang, just when you think you've heard it all in cancer treatment, Fortis Healthcare drops a bombshell: India’s first upright proton therapy system. Boom! This isn't your run-of-the-mill radiation treatment we're talking about here. This is the futuristic flair of the MEVION S250-FIT™, featuring upright...

Continue Reading
Austin PostalAnnex Changes Hands After 19 Years

Updated Category News Views 2

A Seamless Transition in Austin's PostalAnnex Legacy You know when a business digs its roots deep, becoming more than just a place but a part of the community fabric? That's what’s playing out at the PostalAnnex on W Parmer Lane, Austin. After nearly two decades, this battered yet steadfast hub of office and shipping services is swapping hands, all in the name of...

Continue Reading
Innventure Faces Major Lawsuit Amidst Market Turmoil

Updated Category News Views 0

The Plot Thickens with Innventure's DarkNX Project Buckle up, fellow market sling-riders; the Innventure tale is a rocky one for the books. Imagine this: You’ve plunked down your hard-earned cash on Innventure Inc. (NASDAQ: INV), lured by their glowing pronouncements about a supposed golden egg project, the Accelsius DarkNX data-center deal. A big talk about...

Continue Reading
Stoke Space Raises $1B; XTEND AI Hits NYSE

Updated Category News Views 1

A Billion-Dollar Boost for Stoke Space Ever catch wind of a company hauling in a cool billion and shrug it off? Me neither. Stoke Space Technologies just locked down $1 billion in Series E funding. This ain't some pocket change—the kind of dough you need when you're eyeing stars and plotting orbital voyages. They're gearing up for a 2027 mission with their Nova...

Continue Reading
Big Wins at Americas Cardroom's $15M Venom Series

Updated Category News Views 1

High Stakes and Huge Paydays: The Venom Breakdown Alright, folks, here's a tale of how the cards fell in one of the most electrifying poker standoffs at Americas Cardroom. With prize pools clocking in at a staggering $15.095 million, the Dual Mystery Bounty Venoms really stacked the chips high. From the gritty, bustling halls of the internet to the proverbial green-felt...

Continue Reading
AllyGPO Shines as Top Innovator in Health Tech

Updated Category News Views 2

Innovative Excellence in Healthcare Tech It's not every day you see a specialty group purchasing organization like AllyGPO snagging a spot on Fast Company's esteemed list of Best Workplaces for Innovators. Making it into the top half at number 40 in 2026, it’s a testament to a company really leaning into employee-driven innovation. And, buddy, this ain't just corporate...

Continue Reading

Top 5 Most Recently Viewed Articles

Guardforce AI Showcases Revolutionary AI Solutions in Thailand

Updated Category News Views 106

Guardforce AI Launches Innovative Solutions Guardforce AI Co., Limited (NASDAQ: GFAI, GFAIW), a leader in integrated security solutions, is stepping into a new era of technology by introducing its latest innovations in Thailand. The recent rebranding event hosted by Guardforce Cash Solutions Security (Thailand) Company Limited revealed its smart solutions and applications...

Continue Reading
First Trust Intermediate Duration Fund Announces Monthly Dividend

Updated Category News Views 53

First Trust Intermediate Duration Preferred & Income Fund Dividend Announcement First Trust Intermediate Duration Preferred & Income Fund (NYSE: FPF) has announced a distribution for its shareholders. The fund's monthly common share distribution will be $0.1375 per share. This announcement reflects the fund's dedication to providing consistent returns to its investors....

Continue Reading
Investors urged to act as potential XPEL claims are investigated

Updated Category News Views 95

Investors Urged to Seek Justice for Losses in XPEL Faruqi & Faruqi, LLP’s Securities Litigation Partner James (Josh) Wilson is encouraging investors who have lost over $100,000 in XPEL to get in touch and explore their options. If you’ve experienced losses exceeding $100,000 from investing in XPEL stock or its options and want to discuss your legal rights, feel free...

Continue Reading
Celebrate Creativity with HitPaw's Exciting Easter Sale 2025

Updated Category News Views 112

HitPaw Unveils Exciting Easter Savings for Creators HitPaw, a renowned name in multimedia software solutions, is rolling out an impressive Easter Sale that aims to revolutionize how creators work with digital media. As the bright colors of Easter remind us of creativity and renewal, HitPaw is launching its 'Hop into Easter Savings' promotion to empower users in the...

Continue Reading
BioSyent Announces Earnings Release Schedule for 2024 Results

Updated Category News Views 251

Upcoming Earnings Release for BioSyent BioSyent Inc., a dynamic specialty pharmaceutical company listed on the TSX Venture under the symbol RX, is gearing up to announce its financial performance for the fourth quarter and the entire year of 2024. The earnings report is set to be released after market hours on an upcoming Thursday in mid-March. This report is highly...

Continue Reading